Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2006 Sep;44(9):3405–3408. doi: 10.1128/JCM.00730-06

Molecular Epidemiology of Multidrug-Resistant Mycobacterium bovis Isolates with the Same Spoligotyping Profile as Isolates from Animals

Beatriz Romero 1, Alicia Aranaz 1,*, Lucía de Juan 1, Julio Álvarez 1, Javier Bezos 1, Ana Mateos 1, Enrique Gómez-Mampaso 2, Lucas Domínguez 1
PMCID: PMC1594710  PMID: 16954286

Abstract

PCR-based characterization techniques have been adopted in most laboratories for Mycobacterium bovis typing. We report a molecular characterization of human multidrug-resistant M. bovis isolates and three bovine isolates that share the spoligotyping profile. The analysis of the direct repeat region showed that both groups differed in the presence of spacers not included in the current membrane. They were also distinguished by two out of the nine mycobacterial interspersed repetitive unit variable-number tandem repeat loci tested, indicating that the human infection was not acquired from the cattle from which isolates were obtained. These results highlight that a combination of techniques is required for appropriate discrimination, even for those spoligotypes that have a low frequency.


Mycobacterium bovis causes tuberculosis in cattle and other animals, and its implication in human tuberculosis has been recognized since the beginning of the twentieth century (21). In industrialized countries, human infection with M. bovis has been largely controlled through pasteurization of cow's milk, abattoir inspection, and culling of cattle reacting to compulsory diagnosis (tuberculin test). In spite of this, several cases of human tuberculosis caused by M. bovis have been described in recent years (6-8, 12, 17, 20), although some human M. bovis infections could be attributed to a possible endogenous reactivation of a historically acquired infection (11). On the other hand, some new cases of human M. bovis tuberculosis have also been associated with the consumption of dairy products, for instance, unpasteurized cheeses on the United States-Mexico border (7, 17, 35). Thereby, cases of human M. bovis have been related to immigrants or to people who have contracted the infection in countries where eradication programs are patchy or nonexistent (35). Moreover, several of these studies also found an association between human M. bovis disease and human immunodeficiency virus coinfection, showing tuberculosis to be an opportunistic disease in immunodepressed patients (5, 7).

In Spain, less than 1% of clinically diagnosed cases of tuberculosis that are subsequently proven bacteriologically are attributed to M. bovis (28). From December 1993 to February 1995, 19 cases of primary M. bovis tuberculosis were detected in two big hospitals in central Spain (12). Afterwards, the outbreak spread to other cities and countries (18, 23, 27). These human isolates were resistant to 11 drugs (12). These isolates were characterized by spoligotyping (direct variable repeat [DVR] spacer oligonucleotide typing [15] and restriction fragment length polymorphism-IS6110 [RFLP-IS6110]) (32), showing two different profiles, group A and group B, by both techniques (3).

Advances in molecular characterization have provided tools to enhance our knowledge of M. bovis dissemination and tuberculosis control. PCR-based characterization techniques such as spoligotyping (15) and mycobacterial interspersed repetitive unit (MIRU) variable-number tandem repeat (VNTR) typing (9, 31) have been adopted in most laboratories for M. bovis typing because they are faster, simpler, and cost-effective, with the added advantage that results are qualitative (present or absent or in the form of a number). The degree of differentiation and reproducibility is good, but spoligotyping has a lower discriminatory power than MIRU-VNTR (1, 16).

The target of this study was to search for the existence of M. bovis isolates of animal origin with the same spoligotyping pattern and, if found, to determine whether or not human and animal M. bovis isolates are clonal using molecular characterization. This finding may indicate direct or indirect cattle-to-human transmission.

Surveillance and monitoring system of animal tuberculosis.

As part of the surveillance and monitoring system of animal tuberculosis employed by the Spanish Ministry of Agriculture, Fisheries, and Food, we maintain a Spanish database of spoligotyping profiles of M. bovis of domestic and wild animal origin, which consists of around 3,500 strains grouped in 200 spoligotypes. We identified the same profile involved in the multidrug-resistant (MDR) human outbreak (3) in only three M. bovis isolates from three cattle in a farm in central Spain (Hexacode 63-5F-5E-7F-FF-60, SB0426; http://www.mbovis.org).

M. bovis isolates.

The first (93/R1) and the last (95/R4) isolates of the human outbreak of MDR M. bovis in the hospital in Madrid, previously classified within the group A (12), and the three isolates from cattle slaughtered in the year 2000 (00/487, 00/491, and 00/583), which shared the same spoligotyping profile, SB0426 (Fig. 1), were studied. Isolates were grown on Löwenstein Jensen with pyruvate or Coletsos media (Biomedics, Madrid, Spain).

FIG. 1.

FIG. 1.

Spoligotyping pattern (SB0426) found in two MDR M. bovis isolates from humans (R1/93 and R4/95) and three cattle M. bovis isolates from the same farm (00/487, 00/491, and 00/583). Spoligotyping was performed on a commercial membrane (Isogen Bioscience BV, Maarssen, The Netherlands) following a standard protocol (15). A clinical isolate of M. tuberculosis was used as a control.

Drug susceptibility.

The susceptibility test of the cattle isolates was performed by the standard proportion method (4) using the following antibiotics: isoniazid (INH; 0.2 and 1 μg/ml), rifampin (RIF; 1 μg/ml), streptomycin (2 and 10 μg/ml), ethambutol (5 and 10 μg/ml), and ofloxacin (2.5 μg/ml). The cattle isolates were sensitive to the antibiotics tested, unlike the human isolates, which were described as resistant to these drugs.

DR region polymorphism.

A loopful of each M. bovis isolate was resuspended in 200 μl of sterile purified water, heat inactivated for 10 min, and used as template. The 5′ fragment of this region was amplified with primers DR681 (5′ CGGCTTGTCAGCGCAGAGGAG 3′) and sp15R (5′ GGCAGCCCCGAGTACTCGCT 3′) (Roche Molecular Biochemical, Berlin, Germany), which are based on known sequences of nucleotides 681 to 701 and genomic spacer 15, nucleotides 1321 to 1340, respectively (GenBank accession no. 929733 [genome number Z48304]; http://www.ncbi.nlm.nih.gov/GenBank). The DNA was inoculated in a 50-μl PCR mixture containing 10× standard reaction buffer including 2 mM MgCl2 (Biotools B&M Labs, Madrid, Spain), 400 μM of deoxynucleoside triphosphate (dNTP mix; Biotools), 0.64 μM of each primer, and 0.2 U of Taq Ultratools (Biotools). Amplification was carried out in a thermal cycler PTC-100 following the conditions as previously described (34).

PCR products were checked on 2% agarose gels and examined under UV light after staining with ethidium bromide. The amplification products obtained were purified with the QIAquick PCR purification kit (QIAGEN GmbH, Hilden, Germany) and sequenced with the DyeDeoxy (dRhodamine) Terminator cycle sequencing kit in an automatic ABI Prism 373 DNA sequencer (Applied Biosystems) (CIB Sequencing Facilities, Madrid, Spain). The sequences from the amplified products were aligned and compared with the CLUSTALW application software (http://www.es.embnet.org/cgi-bin/clustalw.cgi), using the M. bovis AF2122/97 strain as reference (accession no. BX248343).

The available spoligotyping membrane, as described by Kamerbeek et al. (15), classified the human and animal isolates into the same group. However, the sequence analysis of the region between nucleotide 681 and the 15th spacer (given in the supplemental material) revealed hidden polymorphisms. Human and cattle M. bovis isolates showed differences in the presence of spacers with genomic numbers 6, 7, 8, and 11 (numbering according to van Embden et al. [33]) (Table 1), which are not included in the current spoligotyping membrane.

TABLE 1.

Presence or absence of spacers detected by sequencing of a fragment of the 5′ region of the DR locus (accession no. BX248343)

Isolate(s) tested Detection of DVR for genomic order (membrane order)a:
1 2 (1) 3 (2) 5 6 7 8 11 12 (4) 13 (5) 14 (6) 15 (7)
AF2122/97 + + + + + + + + + + +
Human + + + + + + + + + +
Cattle + + + + + +
a

Spacers are numbered according to a previous designation for oligonucleotide (33) and as bound to the membrane (15). +, presence of the DVR (direct repeat and spacer); −, absence of the DVR. The spacers 4, 9, and 10 are absent in the reference strain and studied isolates.

MIRU-VNTR analysis.

These isolates were also compared by analyzing nine MIRU-VNTR loci (9, 25, 29, 31). PCR was performed as previously described. Amplicon sizes were estimated by electrophoresis on a 2.5% agarose gel at 45 V for 2 h, using a 100-bp ladder (Biotools), and the number of repeats was calculated (www.ibl.fr/mirus/mirus.html) (9, 25, 29).

The cattle and human isolates differed in a copy at ETR-A (6 and 5 copies, respectively) and at QUB-3232 (7 and 6 copies, respectively) (Fig. 2). However, cattle and human groups did not differ in the number of copies at ETR-B (4 copies), QUB-11a (10 copies), QUB-11b (2 copies), QUB-26 (5 copies), MIRU 4 (3 copies), MIRU 20 (2 copies), and MIRU 40 (2 copies).

FIG. 2.

FIG. 2.

MIRU-VNTR results at ETR-A (A) and QUB-3232 (B) (polymorphic loci) in the cattle and human M. bovis isolates. Lanes 1 and 9, 100-bp ladder; lane 2, 00/487; lane 3, 00/491; lane 4, 00/583; lane 5, 93/R3; lane 6, 95/R4; lane 7, negative control; lane 8, PCR positive control (Mycobacterium tuberculosis, clinical isolate).

The molecular characterization rules out these cattle isolates as direct sources of the MDR human outbreak. Spoligotyping is considered a useful typing method for Mycobacterium tuberculosis complex organisms, at least at the level of a first screening (15, 24), as has been shown in its application in routine epidemiological studies in animal isolates (2, 13). However, its level of discrimination may not be enough to establish the definitive identity. In that sense, these results highlight that a combination of techniques is required for appropriate discrimination, even for those spoligotypes that have a low frequency. Furthermore, the design of a new spoligotyping membrane that complements the available one would be essential to improving the degree of strain differentiation.

Polymorphic MIRU-VNTR loci have been exploited for M. bovis typing (14, 26, 29, 30), although in this study only two out of the nine loci tested were able to distinguish both groups of isolates. VNTR typing could be a good discriminatory typing method, nevertheless, this technique is not yet standardized, and it is necessary to assess the discriminatory power of each polymorphic locus alone and in combination with others before its extended use. Due to the allelic diversity of loci among M. bovis isolates in different geographical areas, the most appropriate combination of VNTRs for molecular epidemiological studies should be investigated. As has been established for spoligotyping patterns, a database of VNTR profiles would facilitate the tracking of M. bovis strains.

To date, we have not identified an animal origin for the human outbreak. Risk of infection from livestock has been reduced as a result of eradication programs. Nevertheless, other hazards have emerged that should be controlled, such as consumption of handmade raw-milk products (19, 35) or contact with M. bovis-infected game animals (2, 10, 22).

It is tempting to speculate about the origin of the human isolates. In the 1950s to 1960s the use of INH as a growth promoter in cattle before slaughtering was a common practice in Spain and might have resulted in the development of resistance. We hypothesize that the first human isolate may be a reactivation of an infection acquired at that time. Because diagnosis is commonly based on commercial probes directed to the M. tuberculosis complex, this isolate may have been misdiagnosed as M. tuberculosis. The treatment of the patient with the recommended therapy of INH, RIF, and pyrazinamide (to which all M. bovis isolates are naturally resistant) would have been in fact a monotherapy with RIF that led to multidrug resistance.

In summary, the results obtained with detailed molecular characterization allowed us to distinguish the human and cattle M. bovis isolates and determine that to date, there is no evidence of Spanish animal origin (at least, in recent times) of the multidrug-resistant human outbreak. Therefore, the initial hypothesis of nosocomial infection (12) seems to be the most credible. Spoligotyping may not be useful to determine that two strains are closely related without the support provided by basic epidemiology. Therefore, the application of other techniques is needed. In addition, both human and bovine tuberculosis monitoring are essential in the control and eradication programs of tuberculosis.

Supplementary Material

[Supplemental material]

Acknowledgments

A. Aranaz has a fellowship from the Ramon y Cajal Programme (Spanish Ministry of Science and Technology/U.C.M.). This research was funded by project AGL 2001-2029 of the Spanish Ministry of Science and Technology and by the Spanish Ministry of Agriculture, Fisheries, and Food.

We thank the staff of the SADNA (C.I.B. Madrid) for sequencing. We are grateful to M. Gilmour for careful revision of the manuscript. We thank A. Cabello, J. L. Paramio, and J. L. Sáez-Llorente for their continuous encouragement.

Footnotes

Supplemental material for this article may be found at http://jcm.asm.org/.

REFERENCES

  • 1.Allix, C., K. Walravens, C. Saegerman, J. Godfroid, P. Supply, and M. Fauville-Dufaux. 2006. Evaluation of the epidemiological relevance of variable-number tandem-repeat genotyping of Mycobacterium bovis and comparison of the method with IS6110 restriction fragment length polymorphism analysis and spoligotyping. J. Clin. Microbiol. 44:1951-1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Aranaz, A., L. de Juan, N. Montero, C. Sánchez, M. Galka, C. Delso, J. Álvarez, B. Romero, J. Bezos, A. I. Vela, V. Briones, A. Mateos, and L. Domínguez. 2004. Bovine tuberculosis (Mycobacterium bovis) in wildlife in Spain. J. Clin. Microbiol. 42:2602-2608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Blázquez, J., E. de los Monteros, S. Samper, C. Martín, A. Guerrero, J. Cobo, J. van Embden, F. Baquero, and E. Gómez-Mampaso. 1997. Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J. Clin. Microbiol. 35:1390-1393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Canetti, G., N. Rist, and J. Grosset. 1963. Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation. Rev. Tuberc. Pneumol. (Paris) 27:217-272. [PubMed] [Google Scholar]
  • 5.Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009-1021. [DOI] [PubMed] [Google Scholar]
  • 6.Cousins, D. V., and D. J. Dawson. 1999. Tuberculosis due to Mycobacterium bovis in the Australian population: cases recorded during 1970-1994. Int. J. Tuberc. Lung Dis. 3:715-721. [PubMed] [Google Scholar]
  • 7.Dankner, W. M., N. J. Waecker, M. A. Essey, K. Moser, M. Thompson, and C. E. Davis. 1993. Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore) 72:11-37. [PubMed] [Google Scholar]
  • 8.Fanning, A., and S. Edwards. 1991. Mycobacterium bovis infection in human beings in contact with elk (Cervus elaphus) in Alberta, Canada. Lancet 338:1253-1255. [DOI] [PubMed] [Google Scholar]
  • 9.Frothingham, R., and W. A. Meeker-O'Connell. 1998. Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology 144:1189-1196. [DOI] [PubMed] [Google Scholar]
  • 10.Gortázar, C., J. Vicente, S. Samper, J. M. Garrido, I. G. Fernández-De-Mera, P. Gavin, R. A. Juste, C. Martín, P. Acevedo, M. de la Puente, and U. Hofle. 2005. Molecular characterization of Mycobacterium tuberculosis complex isolates from wild ungulates in south-central Spain. Vet. Res. 36:43-52. [DOI] [PubMed] [Google Scholar]
  • 11.Grange, J. M., and M. D. Yates. 1994. Zoonotic aspects of Mycobacterium bovis infection. Vet. Microbiol. 40:137-151. [DOI] [PubMed] [Google Scholar]
  • 12.Guerrero, A., J. Cobo, J. Fortún, E. Navas, C. Quereda, A. Asensio, J. Cañón, J. Blázquez, and E. Gómez-Mampaso. 1997. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet 350:1738-1742. [DOI] [PubMed] [Google Scholar]
  • 13.Haddad, N., A. Ostyn, C. Karoui, M. Masselot, M. F. Thorel, S. L. Hughes, J. Inwald, R. G. Hewinson, and B. Durand. 2001. Spoligotype diversity of Mycobacterium bovis strains isolated in France from 1979 to 2000. J. Clin. Microbiol. 39:3623-3632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hilty, M., C. Diguimbaye, E. Schelling, F. Baggi, M. Tanner, and J. Zinsstag. 2005. Evaluation of the discriminatory power of variable number tandem repeat (VNTR) typing of Mycobacterium bovis strains. Vet. Microbiol. 109:217-222. [DOI] [PubMed] [Google Scholar]
  • 15.Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kremer, K., C. Arnold, A. Cataldi, M. C. Gutiérrez, W. H. Haas, S. Panaiotov, R. A. Skuce, P. Supply, A. G. van der Zanden, and D. van Soolingen. 2005. Discriminatory power and reproducibility of novel DNA typing methods for Mycobacterium tuberculosis complex strains. J. Clin. Microbiol. 43:5628-5638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.LoBue, P. A., W. Betacourt, C. Peter, and K. S. Moser. 2003. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994-2000. Int. J. Tuberc. Lung Dis. 7:180-185. [PubMed] [Google Scholar]
  • 18.Long, R., E. Nobert, S. Chomyc, J. van Embden, C. McNamee, R. R. Duran, J. Talbot, and A. Fanning. 1999. Transcontinental spread of multidrug-resistant Mycobacterium bovis. Am. J. Respir. Crit. Care Med. 159:2014-2017. [DOI] [PubMed] [Google Scholar]
  • 19.Milian, F., L. M. Sánchez, P. Toledo, C. Ramírez, and M. A. Santillan. 2000. Descriptive study of human and bovine tuberculosis in Queretaro, Mexico. Rev. Latinoam. Microbiol. 42:13-19. [PubMed] [Google Scholar]
  • 20.Nitta, A. T., L. S. Knowles, J. Kim, E. L. Lehnkering, L. A. Borenstein, P. T. Davidson, S. M. Harvey, and M. L. De Koning. 2002. Limited transmission of multidrug-resistant tuberculosis despite a high proportion of infectious cases in Los Angeles County, California. Am. J. Respir. Crit. Care Med. 165:812-817. [DOI] [PubMed] [Google Scholar]
  • 21.O'Reilly, L. M., and C. J. Daborn. 1995. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber. Lung Dis. 76(Suppl. 1):1-46. [DOI] [PubMed] [Google Scholar]
  • 22.Parra, A., J. Larrasa, A. García, J. M. Alonso, and J. H. de Mendoza. 2005. Molecular epidemiology of bovine tuberculosis in wild animals in Spain: a first approach to risk factor analysis. Vet. Microbiol. 110:293-300. [DOI] [PubMed] [Google Scholar]
  • 23.Rivero, A., M. Márquez, J. Santos, A. Pinedo, M. A. Sánchez, A. Esteve, S. Samper, and C. Martín. 2001. High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin. Infect. Dis. 32:159-161. [DOI] [PubMed] [Google Scholar]
  • 24.Roring, S., D. Brittain, A. E. Bunschoten, M. S. Hughes, R. A. Skuce, J. D. van Embden, and S. D. Neill. 1998. Spacer oligotyping of Mycobacterium bovis isolates compared to typing by restriction fragment length polymorphism using PGRS, DR and IS6110 probes. Vet. Microbiol. 61:111-120. [DOI] [PubMed] [Google Scholar]
  • 25.Roring, S., A. Scott, D. Brittain, I. Walker, G. Hewinson, S. Neill, and R. Skuce. 2002. Development of variable-number tandem repeat typing of Mycobacterium bovis: comparison of results with those obtained by using existing exact tandem repeats and spoligotyping. J. Clin. Microbiol. 40:2126-2133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Roring, S., A. N. Scott, H. R. Glyn, S. D. Neill, and R. A. Skuce. 2004. Evaluation of variable number tandem repeat (VNTR) loci in molecular typing of Mycobacterium bovis isolates from Ireland. Vet. Microbiol. 101:65-73. [DOI] [PubMed] [Google Scholar]
  • 27.Samper, S., C. Martín, A. Pinedo, A. Rivero, J. Blázquez, F. Baquero, D. van Soolingen, and J. van Embden. 1997. Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS 11:1237-1242. [DOI] [PubMed] [Google Scholar]
  • 28.Sauret, J., R. Jolis, V. Ausina, E. Castro, and R. Cornudella. 1992. Human tuberculosis due to Mycobacterium bovis: report of 10 cases. Tuber. Lung Dis. 73:388-391. [DOI] [PubMed] [Google Scholar]
  • 29.Skuce, R. A., T. P. McCorry, J. F. McCarroll, S. M. Roring, A. N. Scott, D. Brittain, S. L. Hughes, R. G. Hewinson, and S. D. Neill. 2002. Discrimination of Mycobacterium tuberculosis complex bacteria using novel VNTR-PCR targets. Microbiology 148:519-528. [DOI] [PubMed] [Google Scholar]
  • 30.Skuce, R. A., S. W. McDowell, T. R. Mallon, B. Luke, E. L. Breadon, P. L. Lagan, C. M. McCormick, S. H. McBride, and J. M. Pollock. 2005. Discrimination of isolates of Mycobacterium bovis in Northern Ireland on the basis of variable numbers of tandem repeats (VNTRs). Vet. Rec. 157:501-504. [DOI] [PubMed] [Google Scholar]
  • 31.Supply, P., E. Mazars, S. Lesjean, V. Vincent, B. Gicquel, and C. Locht. 2000. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol. Microbiol. 36:762-771. [DOI] [PubMed] [Google Scholar]
  • 32.van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, and T. M. Shinnick. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.van Embden, J. D., T. van Gorkom, K. Kremer, R. Jansen, B. A. Der Zeijst, and L. M. Schouls. 2000. Genetic variation and evolutionary origin of the direct repeat locus of Mycobacterium tuberculosis complex bacteria. J. Bacteriol. 182:2393-2401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.van Soolingen, D., P. E. de Haas, P. Hermans, and J. van Embden. 1995. Manual for fingerprinting of M. tuberculosis strains. The National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
  • 35.Winter, A., C. Driver, M. Macaraig, C. Clark, S. S. Munsiff, C. Pichardo, J. Jereb, P. LoBue, and M. Lynch. 2005. Tuberculosis cases caused by Mycobacterium bovis infections, New York City, 2001-2004. Morb. Mortal. Wkly. Rep. 54:605-608. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Supplemental material]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES